Human immunodeficiency virus reverse transcriptase substrate-induced conformational changes and the mechanism of inhibition by nonnucleoside inhibitors.
- 15 August 1995
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 92 (17) , 8046-8049
- https://doi.org/10.1073/pnas.92.17.8046
Abstract
A combination of transient kinetic and equilibrium titration methods has been used to show that both primer/template and nucleotide binding to human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are two-step processes. In both cases, after initial formation of relatively weakly bound states, isomerization reactions lead to tightly bound states. In the case of deoxynucleotide binding to the reverse transcriptase-primer/template complex, the second step in the interaction is rate-limiting in the overall reaction during processive polymerization. Discrimination against incorrect nucleotides occurs both in the initial weak binding and in the second step but is purely kinetic in the second step (as opposed to thermodynamic in the first step). Nonnucleoside inhibitors have a relatively small effect on nucleotide-binding steps (overall affinity is reduced by a factor of ca. 10), while the affinity of the primer/template duplex is increased by at least a factor of 10. The major effect of nonnucleoside inhibitors is on the chemical step (nucleotide transfer).Keywords
This publication has 15 references indexed in Scilit:
- Insights into DNA Polymerization Mechanisms from Structure and Function Analysis of HIV-1 Reverse TranscriptaseBiochemistry, 1995
- Kinetics of interaction of HIV reverse transcriptase with primer/templateBiochemistry, 1993
- Mechanism and fidelity of HIV reverse transcriptase.Journal of Biological Chemistry, 1992
- Crystal Structure at 3.5 Å Resolution of HIV-1 Reverse Transcriptase Complexed with an InhibitorScience, 1992
- Structure of HIV-1 reverse transcriptase/DNA complex at 7 Å resolution showing active site locationsNature, 1992
- Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication.Proceedings of the National Academy of Sciences, 1991
- Interaction of fluorescently labeled dideoxynucleotides with HIV-1 reverse transcriptaseBiochemistry, 1991
- An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo-[4,5,1-jk] [1,4]benzodiazepin-2 (1H)-one and -thione derivatives.Proceedings of the National Academy of Sciences, 1991
- Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase InhibitorScience, 1990
- Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivativesNature, 1990